Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
Turkey (Türkiye)
Enrollment target
~30 participants
Started
February 2026
Primary completion
February 2027
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sarp Yoldas, MD
Istanbul University - Cerrahpasa